{
    "nctId": "NCT05935059",
    "briefTitle": "The Efficacy of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery.",
    "officialTitle": "Evaluation of the Efficacy of Perioperative Administration of Tianeptine Versus Pregabalin on Acute and Chronic Post Mastectomy Pain After Breast Cancer Surgery. A Double-Blinded Randomized Controlled Trial.",
    "overallStatus": "RECRUITING",
    "conditions": "Post-mastectomy Pain Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 90,
    "primaryOutcomeMeasure": "the percentage of patients who developed Post Mastectomy Pain Syndrome (PMPS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Breast cancer female patients.\n2. ASA class II and III.\n3. Age \u2265 18 and \u2264 60 Years.\n4. Body mass index (BMI): \\> 20 kg/m2 and \\< 35 kg/m2.\n5. Type of surgery; elective breast cancer surgery (either modified radical mastectomy or conservative breast surgery) combined with axillary dissection.\n\nExclusion Criteria:\n\n1. Patient refusal.\n2. Age \\<18 years or \\>65 years.\n3. BMI \\<20 kg/m2 and \\>35 kg/m2.\n4. Known sensitivity or contraindication to drugs used in the study (Pregabalin , Tianeptine , NSAIDs, or morphine ).\n5. History of psychiatric disorders or history of major depression.\n6. History of chronic pain that necessitates morphine at a daily dose of 30 mg or more (or equivalent opioids).\n7. history of gapabentenoids or antidepressant intake in the preceding three months.\n8. Major medical conditions.\n9. Pregnancy or lactation.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}